insights_auto
Prečo akcie BOI stúpli 2,05%?
Preskúmať podrobnejšiechevron_right
BOI:EPA
Boiron
19,90 €
arrow_upward
+2,05%(+0,40) 1 d.
6. 11., 17:35:11 GMT+1 · EUR
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre BOI…
Otvoriť
19,90 €
Vysoká
19,90 €
Nízka
19,20 €
Trh. kap.
350,39 mil.
Priem. obj.
4,95 tis.
Objem
4,25 tis.
Pomer cena/zárobky
13,19
Max. za 52 týž.
32,25 €
Min. za 52 týž.
16,90 €
Výnosy na akciu
1,51 €
Akcie v obehu
17,55 mil.
Počet zamestnancov
3 tis.
Otvoriť
19,90 €
Vysoká
19,90 €
Nízka
19,20 €
Trh. kap.
350,39 mil.
Priem. obj.
4,95 tis.
Objem
4,25 tis.
Pomer cena/zárobky
13,19
Max. za 52 týž.
32,25 €
Min. za 52 týž.
16,90 €
Výnosy na akciu
1,51 €
Akcie v obehu
17,55 mil.
Počet zamestnancov
3 tis.
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
The Motley Fool
·
pred 18 minútami
3 Internet Giants to Hold for the Next 10 Years
Fox Business
·
pred 13 hodinami
Nasdaq rallies as chip stocks recover from brutal losses
Bloomberg.com
·
pred 22 hodinami
Fast-Money Systematic Funds Stoked $2.3 Trillion Tech-Stock Rout
Investor's Business Daily
·
pred 8 hodinami
Futures: Market Needs Repair; These Big Winners Are Broken
Profil
Boiron is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it had a workforce of 2,779 and turnover of € 313 million. It is a member of the CAC Small stock index.
In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations.
Products of Boiron include mono- and poly-preparations, which Boiron refer to as "proprietary drugs".
Homeopathy is a pseudoscience with no evidence of effectiveness for stated claims or plausible mechanism of medicinal effect, and several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive. Wikipedia
Informácie o subjekte Boiron
Generálny riaditeľ-
Zamestnanci2,62 tis.
Dátum založenia7. 6. 1932
Hlavné sídlo-
OdvetvieHealth Care
Odvetvie-
Webboiron.fr